Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Celsion Corporation (the company was transformed to Imunon (IMNN)) (CLSN)

  • SEC News
  • Jan. 06, 2026, 21:05 UTC
  • 5
  • 1 comments

Director Tardugno Michael H 🟢 acquired 43.8K shares (1 derivative) of Imunon, Inc. (IMNN) at $3.95 Transaction Date: Jan 02, 2026 | Filing ID: 000605

Comment Full text

EyePoint Pharmaceuticals Inc (EYPT)

  • SEC News
  • Jan. 06, 2026, 21:05 UTC
  • 5
  • 1 comments

DICICCO WENDY F 🟢 acquired 40.0K shares (1 derivative) of EyePoint, Inc. (EYPT) at $17.48 Transaction Date: Jan 02, 2026 | Filing ID: 000002

Comment Full text

INVO Bioscience Inc (INVO)

  • SEC News
  • Jan. 06, 2026, 21:05 UTC
  • 5
  • 1 comments

(99% Neutral) INVO FERTILITY, INC. (INVO) Files Form 8-K

Comment Full text

Semler Scientific Inc (SMLR)

  • SEC News
  • Jan. 06, 2026, 21:05 UTC
  • 5
  • 0 comments

New Form 425 - Semler Scientific, Inc. Filed: 2026-01-06 AccNo: 0001104659-26-001289 Size: 87 KB

Comment Full text

Incyte Corporation (INCY)

  • SEC News
  • Jan. 06, 2026, 21:05 UTC
  • 5
  • 1 comments

📋 VIJAY IYENGAR (Officer) plans to sell 96K shares of INCYTE CORPORATION (at $104.35 each, total $10.0M) Filed: Jan 06, 2026 | ID: 000172

Comment Full text

Sol Gel Technologies Ltd (SINT)

  • SEC News
  • Jan. 06, 2026, 21:05 UTC
  • 5
  • 1 comments

Opaleye Management Inc. 🟢 acquired 2.6K shares of Sol-Gel Technologies Ltd. (SLGL) at $42.98 Transaction Date: Jan 02, 2026 | Filing ID: 000588

Comment Full text

Ocular Therapeutix Inc (OCUL)

  • SEC News
  • Jan. 06, 2026, 21:05 UTC
  • 5
  • 1 comments

Kaiser Peter 🟢 acquired 320.0K shares (1 derivative) of OCULAR THERAPEUTIX, INC (OCUL) at $11.82 ($2.8M) Transaction Date: Jan 02, 2026 | Filing ID: 001291

Comment Full text

EyePoint Pharmaceuticals Inc (EYPT)

  • SEC News
  • Jan. 06, 2026, 21:05 UTC
  • 5
  • 1 comments

ANDO GORAN 🟢 acquired 41.5K shares (1 derivative) of EyePoint, Inc. (EYPT) at $17.48 Transaction Date: Jan 02, 2026 | Filing ID: 000002

Comment Full text

Amylyx Pharmaceuticals Inc. (AMLX)

  • SEC News
  • Jan. 06, 2026, 21:05 UTC
  • 5
  • 1 comments

📋 Frates James M (Officer) plans to sell 3K shares of Amylyx Pharmaceuticals, Inc. (at $11.11 each, total $37K) Filed: Jan 06, 2026 | ID: 004407

Comment Full text

Fortress Biotech Inc. (FBIOP)

  • SEC News
  • Jan. 06, 2026, 21:05 UTC
  • 5
  • 1 comments

Fortress Biotech, Inc. 🟢 acquired 111.2K shares of AVENUE THERAPEUTICS, INC. (ATXI) Transaction Date: Jan 02, 2026 | Filing ID: 000004

Comment Full text

Celsion Corporation (the company was transformed to Imunon (IMNN)) (CLSN)

  • SEC News
  • Jan. 06, 2026, 21:05 UTC
  • 5
  • 1 comments

Director Lindborg Stacy 🟢 acquired 56.2K shares (1 derivative) of Imunon, Inc. (IMNN) at $3.95 Transaction Date: Jan 02, 2026 | Filing ID: 000604

Comment Full text

Nuvation Bio Inc. (NUVB)

  • Business News
  • Jan. 06, 2026, 21:05 UTC
  • 6
  • 1 comments

Nuvation Bio Inc. - Nuvation Bio to Present at the 44th Annual J.P. Morgan Healthcare Conference

Market reaction Comment Full text

Rocket Pharmaceuticals Inc (RCKT)

  • SEC News
  • Jan. 06, 2026, 21:05 UTC
  • 6
  • 1 comments

Bjork Elisabeth 🟢 acquired 10.0K shares of ROCKET PHARMACEUTICALS, INC. (RCKT) at $3.44 Transaction Date: Jan 02, 2026 | Filing ID: 000378

Comment Full text

Biodexa Pharmaceuticals PLC (BDRX)

  • Event
  • Jan. 06, 2026, 21:05 UTC
  • 15
  • 1 comments

Biodexa Pharmaceuticals PLC (BDRX) Files Form 6-K

Comment Full text

Iradimed Co (IRMD)

  • SEC News
  • Jan. 06, 2026, 21:05 UTC
  • 5
  • 1 comments

Susi Roger E. 🔴 sold 5.0K shares of IRADIMED CORP (IRMD) at $99.48 Transaction Date: Jan 05, 2026 | Filing ID: 000002

Comment Full text
  • Previous
  • 907
  • 908
  • 909
  • 910
  • 911
  • Next

Search

News categories

  • Technical Exchange News(11014)
  • Event(2495)
  • SEC News(195073)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(126814)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin